Arginine vasopressin immunoreactivity is decreased in the hypothalamic suprachiasmatic nucleus of subjects with suprasellar tumors

Brain Pathology

Volumn 23, Issue 4, 2013, Pages 440-444

  Borgers, Anke J ^a   Fliers, Eric ^a   Siljee, Jacqueline E ^a   Swaab, Dick F ^b   Van Someren, Eus J W ^b   Bisschop, Peter H ^a   Alkemade, Anneke ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

Author keywords

anterior hypothalamus; sleep; suprachiasmatic nucleus; suprasellar tumor; vasopressin

Indexed keywords

ARGIPRESSIN; VASOACTIVE INTESTINAL POLYPEPTIDE;

ADULT; AGED; ARTICLE; AUTOPSY; BRAIN TISSUE; COLORECTAL CARCINOMA; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; MALE; NEUROPATHOLOGY; PROLACTINOMA; SELLA TURCICA TUMOR; SLEEP WAKING CYCLE; SUPRACHIASMATIC NUCLEUS; SUPRASELLAR TUMOR; VISUAL FIELD DEFECT;

AGED; AGED, 80 AND OVER; ARGININE VASOPRESSIN; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; PERCEPTUAL DISORDERS; PITUITARY NEOPLASMS; POSTMORTEM CHANGES; SUPRACHIASMATIC NUCLEUS; VASOACTIVE INTESTINAL PEPTIDE; VISUAL FIELDS;

EID: 84879243554     PISSN: 10156305     EISSN: 17503639     Source Type: Journal    
DOI: 10.1111/bpa.12016     Document Type: Article

References (23)

1. Alkemade A, Unmehopa UA, Wiersinga WM, Swaab DF, Fliers E, (2005) Glucocorticoids decrease thyrotropin-releasing hormone messenger ribonucleic acid expression in the paraventricular nucleus of the human hypothalamus. J Clin Endocrinol Metab 90: 323-327.
2. Biermasz NR, Joustra SD, Donga E, Pereira AM, van, Duinen N, van, Dijk M, et al (2011) Patients previously treated for nonfunctioning pituitary macroadenomas have disturbed sleep characteristics, circadian movement rhythm, and subjective sleep quality. J Clin Endocrinol Metab 96: 1524-1532.
3. Boivin DB, Duffy JF, Kronauer RE, Czeisler CA, (1994) Sensitivity of the human circadian pacemaker to moderately bright light. J Biol Rhythms 9: 315-331.
4. Borgers AJ, Romeijn N, van, Someren E, Fliers E, Alkemade A, Bisschop PH, (2011) Compression of the optic chiasm is associated with permanent shorter sleep duration in patients with pituitary insufficiency. Clin Endocrinol 75: 347-353.
5. Bornebroek M, Haan J, Maat-Schieman ML, van, Duinen SG, Roos RA, (1996) Hereditary cerebral hemorrhage with amyloidosis-Dutch type (HCHWA-D): I-A review of clinical, radiologic and genetic aspects. Brain Pathol 6: 111-114.
6. Buijs RM, Pool CW, Van Heerikhuize JJ, Sluiter AA, Van der Sluis PJ, Ramkema M, et al (1989) Antibodies to small transmitter molecules and peptides: production and application of antibodies to dopamine, serotonin, GABA, vasopressin, vasoactive intestinal polypeptide, neuropeptide Y, somatostatin and substance. Biomed Res 10: 213-221.
7. Foroozan R, (2003) Chiasmal syndromes. Curr Opin Ophthalmol 14: 325-331.
8. Goncharuk VD, Buijs RM, Jhamandas JH, Swaab DF, (2011) Vasopressin (VP) and neuropeptide FF (NPFF) systems in the normal and hypertensive human brainstem. J Comp Neurol 519: 93-124.
9. Hofman MA, Swaab DF, (1983) Diurnal and seasonal rhythms of neuronal activity in the suprachiasmatic nucleus of humans. J Biol Rhythms 8: 283-295.
10. Ingram CD, Ciobanu R, Coculescu IL, Tanasescu R, Coculescu M, Mihai R, (1998) Vasopressin neurotransmission and the control of circadian rhythms in the suprachiasmatic nucleus. Prog Brain Res 119: 351-364.
11. Kalsbeek A, van Heerikhuize JJ, Wortel J, Buijs RM, (1996) A diurnal rhythm of stimulatory input to the hypothalamo-pituitary-adrenal system as revealed by timed intrahypothalamic administration of the vasopressin V1 antagonist. J Neurosci 16: 5555-5565.
12. Lee ML, Swanson BE, de la Iglesia HO, (2009) Circadian timing of REM sleep is coupled to oscillator within the dorsomedial suprachiasmatic nucleus. Curr Biol 19: 848-852.
13. Liou SY, Albers HE, (1989) Single unit response of suprachiasmatic neurons to arginine vasopressin (AVP) is mediated by a V1-like receptor in the hamster. Brain Res 477: 336-343.
14. Minors DS, Waterhouse JM, Wirz-Justice A, (1991) A human phase-response curve to light. Neurosci Lett 133: 36-40.
15. Mistlberger RE, (2005) Circadian regulation of sleep in mammals: role of the suprachiasmatic nucleus. Brain Res Brain Res Rev 49: 429-454.
16. Muller HL, Handwerker G, Gebhardt U, Faldum A, Emser A, Kolb R, Sorensen N, (2006) Melatonin treatment in obese patients with childhood craniopharyngioma and increased daytime sleepiness. Cancer Causes Control 17: 583-589.
17. Moore RY, Speh JC, Leak RK, (2002) Suprachiasmatic nucleus organization. Cell Tissue Res 309: 89-98.
18. Rusak B, (1979) Neural mechanisms for entrainment and generation of mammalian circadian rhythms. Fed Proc 38: 2589-2595.
19. Snow A, Gozal E, Malhotra A, Tiosano D, Perlman R, Vega C, et al (2002) Severe hypersomnolence after pituitary/hypothalamic surgery in adolescents: clinical characteristics and potential mechanisms. Pediatrics 110: e74.
20. Swaab DF, (2003) Suprachiasmatic nucleus (SCN) and pineal gland (Fig. 4A). In: Handbook of Clinical Neurology. The Human Hypothalamus: Basic and Clinical Aspects-Part I: Nuclei of the Human Hypothalamus, Vol. 79., MJ Aminoff, F Boller, DF Swaab, (eds), pp. 63-125. Elsevier: Amsterdam.
21. Twisk JW, (2003) Applied Longitudinal Data Analysis for Epidemiology. A Practical Guide. Cambridge University Press: Cambridge.
22. Van der Klaauw AA, Biermasz NR, Pereira AM, Van Kralingen KW, Dekkers OM, Rabe KF, et al (2008) Patients cured from craniopharyngioma or nonfunctioning pituitary macroadenoma (NFMA) suffer similarly from increased daytime somnolence despite normal sleep patterns compared to healthy controls. Clin Endocrinol 69: 769-774.
23. Van der Sluis PJ, Pool CW, Sluiter AA, (1988) Immunochemical detection of peptides and proteins on press-blots after direct tissue gel isoelectric focusing. Electrophoresis 9: 654-661.